|
Novartis
monoclonal prlr-specific antibodies Monoclonal Prlr Specific Antibodies, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/monoclonal prlr-specific antibodies/product/Novartis Average 90 stars, based on 1 article reviews
monoclonal prlr-specific antibodies - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Novartis
prlr-specific antibodies Prlr Specific Antibodies, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/prlr-specific antibodies/product/Novartis Average 90 stars, based on 1 article reviews
prlr-specific antibodies - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Jackson Laboratory
prlr isoform specific antibodies ![]() Prlr Isoform Specific Antibodies, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/prlr isoform specific antibodies/product/Jackson Laboratory Average 90 stars, based on 1 article reviews
prlr isoform specific antibodies - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: BMC Cancer
Article Title: Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies
doi: 10.1186/1471-2407-10-678
Figure Lengend Snippet: Characterization of PRLR isoform antibodies. A. Western blot analysis indicating specificity of polyclonal antibodies. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Cell lysates were prepared and proteins separated by PAGE. Each isoform specific lysate was probed with each isoform specific antibody. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. Molecular weights are marked as indicated: LF = 93 kDa, SF1a = 57 kDa, SF1b = 38 kDa. Cell lysates from CHO transfected cells were immunoprecipitated with their respective antibodies, then immunoblotted with the same antibodies. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. IP indicates immunoprecipitation. B. Western blot analysis using commercially available PRLR antibody. ECD = antibody recognizing extracellular domain C. Fluorescent immunocytochemical analysis. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Specific staining was observed using isoform specific polyclonal antibodies. The negative control (not shown) lacks primary antibody and appears black. Data shown are representative of triplicate experiments. Magnification 20×.
Article Snippet: After blocking in 5% normal goat serum (
Techniques: Western Blot, Transfection, Immunoprecipitation, Staining, Negative Control
Journal: BMC Cancer
Article Title: Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies
doi: 10.1186/1471-2407-10-678
Figure Lengend Snippet: Immunoanalysis on human xenografts. A. Fluorescent immunohistochemistry was performed on MCF7, MDA-MB-231, or T47D cells which were injected into the cleared fat pads of nude mice; once tumors reached 1 cm 2 (measured in two dimensions), they were excised, formalin fixed, sectioned, and stained with the indicated PRLR isoform specific antibodies. B. Immunohistochemical analysis using DAB as chromogen of MCF7, MDA-MB-231, or T47D xenograft tumors. neg = no primary antibody as negative control; DAPI stain to visualize the presence of cells. Photographs are representative from 5 different tumors for each cell line. Magnification 40×.
Article Snippet: After blocking in 5% normal goat serum (
Techniques: Immunohistochemistry, Injection, Staining, Immunohistochemical staining, Negative Control
Journal: BMC Cancer
Article Title: Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies
doi: 10.1186/1471-2407-10-678
Figure Lengend Snippet: Message for PRLR isoforms in breast carcinomas. RNA was extracted from 7 ductal (left) and 7 lobular (right) carcinomas and qPCR was performed. Data shown are the mean +/- SE of delta delta Ct values relative to SF1a expression.
Article Snippet: After blocking in 5% normal goat serum (
Techniques: Expressing
Journal: BMC Cancer
Article Title: Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies
doi: 10.1186/1471-2407-10-678
Figure Lengend Snippet: Immunohistochemical analysis from ductal breast tissue arrays. Representative photographs taken of ductal carcinoma specimens to demonstrate absent, low, medium, or high amounts of fluorescent red intensity staining. 144 individual ductal specimens were stained with PRLR isoform specific antibodies and analyzed. Scale bar indicates range of red scoring.
Article Snippet: After blocking in 5% normal goat serum (
Techniques: Immunohistochemical staining, Staining
Journal: BMC Cancer
Article Title: Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies
doi: 10.1186/1471-2407-10-678
Figure Lengend Snippet: Immunohistochemical analysis from lobular breast tissue arrays. Representative photographs of lobular carcinoma specimens to demonstrate absent, low, medium, or high amounts of fluorescent red intensity staining. 104 individual lobular specimens were stained with PRLR isoform specific antibodies and analyzed. Scale bar indicates range of red scoring.
Article Snippet: After blocking in 5% normal goat serum (
Techniques: Immunohistochemical staining, Staining